Banner Alzheimer’s Institute

Showing 1 posts of 1 posts found.


Novartis and Amgen halt trials into Alzheimer’s drug after patients get worse

July 12, 2019
Medical Communications Alzheimer's, Amgen, Banner Alzheimer's Institute, Novartis, dementia, pharma, research

Novartis, Amgen and Banner Alzheimer’s Institute have dropped a study into investigational Alzheimer’s drug CNP520 (umibecestat) after some patient’s conditions …

Latest content